Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

This article is part of the supplement: 11th International Symposium on the Cells of the Hepatic Sinusoid and their Relation to Other Cells

Open AccessHighly AccessProceedings

N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1

Frank Murphy1 email, Julian Waung1 email, Jane Collins2 email, Michael JP Arthur1 email, Hideaki Nagase3 email, Derek Mann1 email, R Christopher Benyon1 email and John P Iredale1 email

1Liver group, Division of Infection, Inflammation and Repair, Southampton University, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK

2Mucosal Immunology, Southampton University, Tremona Road, Southampton, UK

3The Kennedy Institute, Imperial College, 1 Aspenlea Road, London W6, UK

author email corresponding author email

Comparative Hepatology 2004, 3(Suppl 1):S8doi:10.1186/1476-5926-2-S1-S8

Published: 14 January 2004

Abstract

Apoptosis of hepatic stellate cells (HSC) has previously been shown to occur during spontaneous resolution of experimental liver fibrosis. TIMP-1 has also been shown to have a key role because of its ability to inhibit apoptosis of HSC via matrix metalloproteinase (MMP) inhibition. This has led to further study of novel substrates for MMPs that might impact on HSC survival. N-Cadherin is known to mediate cell-cell contacts in fibroblasts. In this study we demonstrate that N-Cadherin is expressed by activated rat HSC. Furthermore, during apoptosis of HSC, the N-Cadherin is cleaved into smaller fragments. Apoptosis of HSC may be inhibited by TIMP-1. This is associated with reduced fragmentation of N-Cadherin. N-Cadherin may have an important role in supporting HSC survival while N-Cadherin cleavage may play a part in promoting HSC apoptosis in recovery from liver fibrosis.


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions